Onset of Response with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease
Chris Fourment – Texas Digestive Disease Consultants, PA, Southlake, TX
Timothy E. Ritter – Texas Digestive Disease Consultants, PA, Southlake, TX
Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX
Thomas C. Hardin – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX